Global Semi-solid Dosage Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Semi-solid Dosage Consumption 2016-2026

2.1.2 Semi-solid Dosage Consumption CAGR by Region

2.2 Semi-solid Dosage Segment by Type

2.2.1 Ointment

2.2.2 Paste

2.2.3 Plaster

2.2.4 Gel

2.3 Semi-solid Dosage Sales by Type

2.3.1 Global Semi-solid Dosage Sales Market Share by Type (2016-2021)

2.3.2 Global Semi-solid Dosage Revenue and Market Share by Type (2016-2021)

2.3.3 Global Semi-solid Dosage Sale Price by Type (2016-2021)

2.4 Semi-solid Dosage Segment by Application

2.4.1 Skin

2.4.2 Nasal Cavity

2.4.3 Vaginal Cavity

2.4.4 Rectal Cavity

2.4.5 Other

2.5 Semi-solid Dosage Sales by Application

2.5.1 Global Semi-solid Dosage Sale Market Share by Application (2016-2021)

2.5.2 Global Semi-solid Dosage Revenue and Market Share by Application (2016-2021)

2.5.3 Global Semi-solid Dosage Sale Price by Application (2016-2021)

3 Global Semi-solid Dosage by Company

3.1 Global Semi-solid Dosage Sales Market Share by Company

3.1.1 Global Semi-solid Dosage Sales by Company (2019-2021)

3.1.2 Global Semi-solid Dosage Sales Market Share by Company (2019-2021)

3.2 Global Semi-solid Dosage Revenue Market Share by Company

3.2.1 Global Semi-solid Dosage Revenue by Company (2019-2021)

3.2.2 Global Semi-solid Dosage Revenue Market Share by Company (2019-2021)

3.3 Global Semi-solid Dosage Sale Price by Company

3.4 Global Manufacturers Semi-solid Dosage Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Semi-solid Dosage Product Location Distribution

3.4.2 Players Semi-solid Dosage Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Semi-solid Dosage by Region

4.1 Global Semi-solid Dosage by Region

4.1.1 Global Semi-solid Dosage Sales by Region

4.1.2 Global Semi-solid Dosage Revenue by Region

4.2 Americas Semi-solid Dosage Sales Growth

4.3 APAC Semi-solid Dosage Sales Growth

4.4 Europe Semi-solid Dosage Sales Growth

4.5 Middle East & Africa Semi-solid Dosage Sales Growth

5 Americas

5.1 Americas Semi-solid Dosage Sales by Country

5.1.1 Americas Semi-solid Dosage Sales by Country (2016-2021)

5.1.2 Americas Semi-solid Dosage Revenue by Country (2016-2021)

5.2 Americas Semi-solid Dosage Sales by Type

5.3 Americas Semi-solid Dosage Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Semi-solid Dosage Sales by Region

6.1.1 APAC Semi-solid Dosage Sales by Region (2016-2021)

6.1.2 APAC Semi-solid Dosage Revenue by Region (2016-2021)

6.2 APAC Semi-solid Dosage Sales by Type

6.3 APAC Semi-solid Dosage Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Semi-solid Dosage by Country

7.1.1 Europe Semi-solid Dosage Sales by Country (2016-2021)

7.1.2 Europe Semi-solid Dosage Revenue by Country (2016-2021)

7.2 Europe Semi-solid Dosage Sales by Type

7.3 Europe Semi-solid Dosage Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Semi-solid Dosage by Country

8.1.1 Middle East & Africa Semi-solid Dosage Sales by Country (2016-2021)

8.1.2 Middle East & Africa Semi-solid Dosage Revenue by Country (2016-2021)

8.2 Middle East & Africa Semi-solid Dosage Sales by Type

8.3 Middle East & Africa Semi-solid Dosage Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Semi-solid Dosage Distributors

10.3 Semi-solid Dosage Customer

11 Global Semi-solid Dosage Market Forecast

11.1 Global Semi-solid Dosage Forecast by Region

11.1.1 Global Semi-solid Dosage Forecast by Regions (2021-2026)

11.2.2 Global Semi-solid Dosage Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Semi-solid Dosage Forecast by Type

11.7 Global Semi-solid Dosage Forecast by Application

12 Key Players Analysis

12.1 Johnson & Johnson

12.1.1 Johnson & Johnson Company Information

12.1.2 Johnson & Johnson Semi-solid Dosage Product Offered

12.1.3 Johnson & Johnson Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Johnson & Johnson Main Business Overview

12.1.5 Johnson & Johnson Latest Developments

12.2 Merck & Co

12.2.1 Merck & Co Company Information

12.2.2 Merck & Co Semi-solid Dosage Product Offered

12.2.3 Merck & Co Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Merck & Co Main Business Overview

12.2.5 Merck & Co Latest Developments

12.3 Bayer AG

12.3.1 Bayer AG Company Information

12.3.2 Bayer AG Semi-solid Dosage Product Offered

12.3.3 Bayer AG Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Bayer AG Main Business Overview

12.3.5 Bayer AG Latest Developments

12.4 Hisamitsu Pharmaceutical

12.4.1 Hisamitsu Pharmaceutical Company Information

12.4.2 Hisamitsu Pharmaceutical Semi-solid Dosage Product Offered

12.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Hisamitsu Pharmaceutical Main Business Overview

12.4.5 Hisamitsu Pharmaceutical Latest Developments

12.5 Glenmark Pharmaceuticals

12.5.1 Glenmark Pharmaceuticals Company Information

12.5.2 Glenmark Pharmaceuticals Semi-solid Dosage Product Offered

12.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Glenmark Pharmaceuticals Main Business Overview

12.5.5 Glenmark Pharmaceuticals Latest Developments

12.6 Cipla Ltd

12.6.1 Cipla Ltd Company Information

12.6.2 Cipla Ltd Semi-solid Dosage Product Offered

12.6.3 Cipla Ltd Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Cipla Ltd Main Business Overview

12.6.5 Cipla Ltd Latest Developments

12.7 Nestle SA

12.7.1 Nestle SA Company Information

12.7.2 Nestle SA Semi-solid Dosage Product Offered

12.7.3 Nestle SA Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Nestle SA Main Business Overview

12.7.5 Nestle SA Latest Developments

12.8 Novartis AG

12.8.1 Novartis AG Company Information

12.8.2 Novartis AG Semi-solid Dosage Product Offered

12.8.3 Novartis AG Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Novartis AG Main Business Overview

12.8.5 Novartis AG Latest Developments

12.9 GlaxoSmithKline plc

12.9.1 GlaxoSmithKline plc Company Information

12.9.2 GlaxoSmithKline plc Semi-solid Dosage Product Offered

12.9.3 GlaxoSmithKline plc Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 GlaxoSmithKline plc Main Business Overview

12.9.5 GlaxoSmithKline plc Latest Developments

12.10 Bausch Health Companies

12.10.1 Bausch Health Companies Company Information

12.10.2 Bausch Health Companies Semi-solid Dosage Product Offered

12.10.3 Bausch Health Companies Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Bausch Health Companies Main Business Overview

12.10.5 Bausch Health Companies Latest Developments

12.11 Allergan

12.11.1 Allergan Company Information

12.11.2 Allergan Semi-solid Dosage Product Offered

12.11.3 Allergan Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Allergan Main Business Overview

12.11.5 Allergan Latest Developments

12.12 Biofrontera

12.12.1 Biofrontera Company Information

12.12.2 Biofrontera Semi-solid Dosage Product Offered

12.12.3 Biofrontera Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Biofrontera Main Business Overview

12.12.5 Biofrontera Latest Developments

12.13 Crown Laboratories

12.13.1 Crown Laboratories Company Information

12.13.2 Crown Laboratories Semi-solid Dosage Product Offered

12.13.3 Crown Laboratories Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Crown Laboratories Main Business Overview

12.13.5 Crown Laboratories Latest Developments

12.14 Akorn

12.14.1 Akorn Company Information

12.14.2 Akorn Semi-solid Dosage Product Offered

12.14.3 Akorn Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Akorn Main Business Overview

12.14.5 Akorn Latest Developments

12.15 Ingenus Pharmaceuticals

12.15.1 Ingenus Pharmaceuticals Company Information

12.15.2 Ingenus Pharmaceuticals Semi-solid Dosage Product Offered

12.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Ingenus Pharmaceuticals Main Business Overview

12.15.5 Ingenus Pharmaceuticals Latest Developments

12.16 Sun Pharmaceuticals

12.16.1 Sun Pharmaceuticals Company Information

12.16.2 Sun Pharmaceuticals Semi-solid Dosage Product Offered

12.16.3 Sun Pharmaceuticals Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Sun Pharmaceuticals Main Business Overview

12.16.5 Sun Pharmaceuticals Latest Developments

12.17 Crescita Therapeutics

12.17.1 Crescita Therapeutics Company Information

12.17.2 Crescita Therapeutics Semi-solid Dosage Product Offered

12.17.3 Crescita Therapeutics Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Crescita Therapeutics Main Business Overview

12.17.5 Crescita Therapeutics Latest Developments

12.18 Mylan N.V.

12.18.1 Mylan N.V. Company Information

12.18.2 Mylan N.V. Semi-solid Dosage Product Offered

12.18.3 Mylan N.V. Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 Mylan N.V. Main Business Overview

12.18.5 Mylan N.V. Latest Developments

12.19 Encore Dermatology

12.19.1 Encore Dermatology Company Information

12.19.2 Encore Dermatology Semi-solid Dosage Product Offered

12.19.3 Encore Dermatology Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Encore Dermatology Main Business Overview

12.19.5 Encore Dermatology Latest Developments

12.20 LEO Pharma

12.20.1 LEO Pharma Company Information

12.20.2 LEO Pharma Semi-solid Dosage Product Offered

12.20.3 LEO Pharma Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 LEO Pharma Main Business Overview

12.20.5 LEO Pharma Latest Developments

12.21 Almirall, S.A

12.21.1 Almirall, S.A Company Information

12.21.2 Almirall, S.A Semi-solid Dosage Product Offered

12.21.3 Almirall, S.A Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.21.4 Almirall, S.A Main Business Overview

12.21.5 Almirall, S.A Latest Developments

12.22 Aclaris Therapeutics

12.22.1 Aclaris Therapeutics Company Information

12.22.2 Aclaris Therapeutics Semi-solid Dosage Product Offered

12.22.3 Aclaris Therapeutics Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.22.4 Aclaris Therapeutics Main Business Overview

12.22.5 Aclaris Therapeutics Latest Developments

12.23 Taro Pharmaceutical Industries

12.23.1 Taro Pharmaceutical Industries Company Information

12.23.2 Taro Pharmaceutical Industries Semi-solid Dosage Product Offered

12.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.23.4 Taro Pharmaceutical Industries Main Business Overview

12.23.5 Taro Pharmaceutical Industries Latest Developments

12.24 Teligent Pharma

12.24.1 Teligent Pharma Company Information

12.24.2 Teligent Pharma Semi-solid Dosage Product Offered

12.24.3 Teligent Pharma Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.24.4 Teligent Pharma Main Business Overview

12.24.5 Teligent Pharma Latest Developments

12.25 Perrigo Pharma

12.25.1 Perrigo Pharma Company Information

12.25.2 Perrigo Pharma Semi-solid Dosage Product Offered

12.25.3 Perrigo Pharma Semi-solid Dosage Sales, Revenue, Price and Gross Margin (2019-2021)

12.25.4 Perrigo Pharma Main Business Overview

12.25.5 Perrigo Pharma Latest Developments

13 Research Findings and Conclusion

Table 1. Semi-solid Dosage Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Ointment

Table 3. Major Players of Paste

Table 4. Major Players of Plaster

Table 5. Major Players of Gel

Table 6. Global Semi-solid Dosage Sales by Type (2016-2021) & (Dose)

Table 7. Global Semi-solid Dosage Sales Market Share by Type (2016-2021)

Table 8. Global Semi-solid Dosage Revenue by Type (2016-2021) & ($ million)

Table 9. Global Semi-solid Dosage Revenue Market Share by Type (2016-2021)

Table 10. Global Semi-solid Dosage Sale Price by Type (2016-2021)

Table 11. Global Semi-solid Dosage Sales by Application (2016-2021) & (Dose)

Table 12. Global Semi-solid Dosage Sales Market Share by Application (2016-2021)

Table 13. Global Semi-solid Dosage Value by Application (2016-2021)

Table 14. Global Semi-solid Dosage Revenue Market Share by Application (2016-2021)

Table 15. Global Semi-solid Dosage Sale Price by Application (2016-2021)

Table 16. Global Semi-solid Dosage Sales by Company (2019-2021) & (Dose)

Table 17. Global Semi-solid Dosage Sales Market Share by Company (2019-2021)

Table 18. Global Semi-solid Dosage Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Semi-solid Dosage Revenue Market Share by Company (2019-2021)

Table 20. Global Semi-solid Dosage Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Semi-solid Dosage Producing Area Distribution and Sales Area

Table 22. Players Semi-solid Dosage Products Offered

Table 23. Semi-solid Dosage Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Semi-solid Dosage Sales by Region (2016-2021) (Dose)

Table 27. Global Semi-solid Dosage Sales Market Share by Region (2016-2021)

Table 28. Global Semi-solid Dosage Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Semi-solid Dosage Revenue Market Share by Region (2016-2021)

Table 30. Americas Semi-solid Dosage Sales by Country (2016-2021) & (Dose)

Table 31. Americas Semi-solid Dosage Sales Market Share by Country (2016-2021)

Table 32. Americas Semi-solid Dosage Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Semi-solid Dosage Revenue Market Share by Country (2016-2021)

Table 34. Americas Semi-solid Dosage Sales by Type (2016-2021) & (Dose)

Table 35. Americas Semi-solid Dosage Sales Market Share by Type (2016-2021)

Table 36. Americas Semi-solid Dosage Sales by Application (2016-2021) & (Dose)

Table 37. Americas Semi-solid Dosage Sales Market Share by Application (2016-2021)

Table 38. APAC Semi-solid Dosage Sales by Region (2016-2021) & (Dose)

Table 39. APAC Semi-solid Dosage Sales Market Share by Region (2016-2021)

Table 40. APAC Semi-solid Dosage Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Semi-solid Dosage Revenue Market Share by Region (2016-2021)

Table 42. APAC Semi-solid Dosage Sales by Type (2016-2021) & (Dose)

Table 43. APAC Semi-solid Dosage Sales Market Share by Type (2016-2021)

Table 44. APAC Semi-solid Dosage Sales by Application (2016-2021) & (Dose)

Table 45. APAC Semi-solid Dosage Sales Market Share by Application (2016-2021)

Table 46. Europe Semi-solid Dosage Sales by Country (2016-2021) & (Dose)

Table 47. Europe Semi-solid Dosage Sales Market Share by Country (2016-2021)

Table 48. Europe Semi-solid Dosage Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Semi-solid Dosage Revenue Market Share by Country (2016-2021)

Table 50. Europe Semi-solid Dosage Sales by Type (2016-2021) & (Dose)

Table 51. Europe Semi-solid Dosage Sales Market Share by Type (2016-2021)

Table 52. Europe Semi-solid Dosage Sales by Application (2016-2021) & (Dose)

Table 53. Europe Semi-solid Dosage Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Semi-solid Dosage Sales by Country (2016-2021) & (Dose)

Table 55. Middle East & Africa Semi-solid Dosage Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Semi-solid Dosage Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Semi-solid Dosage Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Semi-solid Dosage Sales by Type (2016-2021) & (Dose)

Table 59. Middle East & Africa Semi-solid Dosage Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Semi-solid Dosage Sales by Application (2016-2021) & (Dose)

Table 61. Middle East & Africa Semi-solid Dosage Sales Market Share by Application (2016-2021)

Table 62. Key and Potential Regions of Semi-solid Dosage

Table 63. Key Application and Potential Industries of Semi-solid Dosage

Table 64. Key Challenges of Semi-solid Dosage

Table 65. Key Trends of Semi-solid Dosage

Table 66. Semi-solid Dosage Distributors List

Table 67. Semi-solid Dosage Customer List

Table 68. Global Semi-solid Dosage Sales Forecast by Region (2021-2026) & (Dose)

Table 69. Global Semi-solid Dosage Consumption Market Forecast by Region

Table 70. Global Semi-solid Dosage Revenue Forecast by Region (2021-2026) & ($ millions)

Table 71. Global Semi-solid Dosage Revenue Market Share Forecast by Region (2021-2026)

Table 72. Americas Semi-solid Dosage Sales Forecast by Country (2021-2026) & (Dose)

Table 73. Americas Semi-solid Dosage Revenue Forecast by Country (2021-2026) & ($ millions)

Table 74. APAC Semi-solid Dosage Sales Forecast by Region (2021-2026) & (Dose)

Table 75. APAC Semi-solid Dosage Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Europe Semi-solid Dosage Sales Forecast by Country (2021-2026) & (Dose)

Table 77. Europe Semi-solid Dosage Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Middle East & Africa Semi-solid Dosage Sales Forecast by Country (2021-2026) & (Dose)

Table 79. Middle East & Africa Semi-solid Dosage Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Global Semi-solid Dosage Sales Forecast by Type (2021-2026) & (Dose)

Table 81. Global Semi-solid Dosage Sales Market Share Forecast by Type (2021-2026)

Table 82. Global Semi-solid Dosage Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 83. Global Semi-solid Dosage Revenue Market Share Forecast by Type (2021-2026)

Table 84. Global Semi-solid Dosage Sales Forecast by Application (2021-2026) & (Dose)

Table 85. Global Semi-solid Dosage Sales Market Share Forecast by Application (2021-2026)

Table 86. Global Semi-solid Dosage Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 87. Global Semi-solid Dosage Revenue Market Share Forecast by Application (2021-2026)

Table 88. Johnson & Johnson Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 89. Johnson & Johnson Semi-solid Dosage Product Offered

Table 90. Johnson & Johnson Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 91. Johnson & Johnson Main Business

Table 92. Johnson & Johnson Latest Developments

Table 93. Merck & Co Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck & Co Semi-solid Dosage Product Offered

Table 95. Merck & Co Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 96. Merck & Co Main Business

Table 97. Merck & Co Latest Developments

Table 98. Bayer AG Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 99. Bayer AG Semi-solid Dosage Product Offered

Table 100. Bayer AG Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 101. Bayer AG Main Business

Table 102. Bayer AG Latest Developments

Table 103. Hisamitsu Pharmaceutical Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 104. Hisamitsu Pharmaceutical Semi-solid Dosage Product Offered

Table 105. Hisamitsu Pharmaceutical Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 106. Hisamitsu Pharmaceutical Main Business

Table 107. Hisamitsu Pharmaceutical Latest Developments

Table 108. Glenmark Pharmaceuticals Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 109. Glenmark Pharmaceuticals Semi-solid Dosage Product Offered

Table 110. Glenmark Pharmaceuticals Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 111. Glenmark Pharmaceuticals Main Business

Table 112. Glenmark Pharmaceuticals Latest Developments

Table 113. Cipla Ltd Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 114. Cipla Ltd Semi-solid Dosage Product Offered

Table 115. Cipla Ltd Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 116. Cipla Ltd Main Business

Table 117. Cipla Ltd Latest Developments

Table 118. Nestle SA Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 119. Nestle SA Semi-solid Dosage Product Offered

Table 120. Nestle SA Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 121. Nestle SA Main Business

Table 122. Nestle SA Latest Developments

Table 123. Novartis AG Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 124. Novartis AG Semi-solid Dosage Product Offered

Table 125. Novartis AG Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 126. Novartis AG Main Business

Table 127. Novartis AG Latest Developments

Table 128. GlaxoSmithKline plc Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 129. GlaxoSmithKline plc Semi-solid Dosage Product Offered

Table 130. GlaxoSmithKline plc Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 131. GlaxoSmithKline plc Main Business

Table 132. GlaxoSmithKline plc Latest Developments

Table 133. Bausch Health Companies Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 134. Bausch Health Companies Semi-solid Dosage Product Offered

Table 135. Bausch Health Companies Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 136. Bausch Health Companies Main Business

Table 137. Bausch Health Companies Latest Developments

Table 138. Allergan Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 139. Allergan Semi-solid Dosage Product Offered

Table 140. Allergan Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 141. Allergan Main Business

Table 142. Allergan Latest Developments

Table 143. Biofrontera Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 144. Biofrontera Semi-solid Dosage Product Offered

Table 145. Biofrontera Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 146. Biofrontera Main Business

Table 147. Biofrontera Latest Developments

Table 148. Crown Laboratories Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 149. Crown Laboratories Semi-solid Dosage Product Offered

Table 150. Crown Laboratories Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 151. Crown Laboratories Main Business

Table 152. Crown Laboratories Latest Developments

Table 153. Akorn Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 154. Akorn Semi-solid Dosage Product Offered

Table 155. Akorn Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 156. Akorn Main Business

Table 157. Akorn Latest Developments

Table 158. Ingenus Pharmaceuticals Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 159. Ingenus Pharmaceuticals Semi-solid Dosage Product Offered

Table 160. Ingenus Pharmaceuticals Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 161. Ingenus Pharmaceuticals Main Business

Table 162. Ingenus Pharmaceuticals Latest Developments

Table 163. Sun Pharmaceuticals Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 164. Sun Pharmaceuticals Semi-solid Dosage Product Offered

Table 165. Sun Pharmaceuticals Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 166. Sun Pharmaceuticals Main Business

Table 167. Sun Pharmaceuticals Latest Developments

Table 168. Crescita Therapeutics Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 169. Crescita Therapeutics Semi-solid Dosage Product Offered

Table 170. Crescita Therapeutics Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 171. Crescita Therapeutics Main Business

Table 172. Crescita Therapeutics Latest Developments

Table 173. Mylan N.V. Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 174. Mylan N.V. Semi-solid Dosage Product Offered

Table 175. Mylan N.V. Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 176. Mylan N.V. Main Business

Table 177. Mylan N.V. Latest Developments

Table 178. Encore Dermatology Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 179. Encore Dermatology Semi-solid Dosage Product Offered

Table 180. Encore Dermatology Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 181. Encore Dermatology Main Business

Table 182. Encore Dermatology Latest Developments

Table 183. LEO Pharma Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 184. LEO Pharma Semi-solid Dosage Product Offered

Table 185. LEO Pharma Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 186. LEO Pharma Main Business

Table 187. LEO Pharma Latest Developments

Table 188. Almirall, S.A Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 189. Almirall, S.A Semi-solid Dosage Product Offered

Table 190. Almirall, S.A Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 191. Almirall, S.A Main Business

Table 192. Almirall, S.A Latest Developments

Table 193. Aclaris Therapeutics Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 194. Aclaris Therapeutics Semi-solid Dosage Product Offered

Table 195. Aclaris Therapeutics Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 196. Aclaris Therapeutics Main Business

Table 197. Aclaris Therapeutics Latest Developments

Table 198. Taro Pharmaceutical Industries Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 199. Taro Pharmaceutical Industries Semi-solid Dosage Product Offered

Table 200. Taro Pharmaceutical Industries Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 201. Taro Pharmaceutical Industries Main Business

Table 202. Taro Pharmaceutical Industries Latest Developments

Table 203. Teligent Pharma Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 204. Teligent Pharma Semi-solid Dosage Product Offered

Table 205. Teligent Pharma Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 206. Teligent Pharma Main Business

Table 207. Teligent Pharma Latest Developments

Table 208. Perrigo Pharma Basic Information, Semi-solid Dosage Manufacturing Base, Sales Area and Its Competitors

Table 209. Perrigo Pharma Semi-solid Dosage Product Offered

Table 210. Perrigo Pharma Semi-solid Dosage Sales (Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2021E)

Table 211. Perrigo Pharma Main Business

Table 212. Perrigo Pharma Latest Developments

List of Figures

Figure 1. Picture of Semi-solid Dosage

Figure 2. Semi-solid Dosage Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Semi-solid Dosage Sales Growth Rate 2016-2026 (Dose)

Figure 7. Global Semi-solid Dosage Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Semi-solid Dosage Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Ointment

Figure 10. Product Picture of Paste

Figure 11. Product Picture of Plaster

Figure 12. Product Picture of Gel

Figure 13. Global Semi-solid Dosage Sales Market Share by Type in 2020

Figure 14. Global Semi-solid Dosage Revenue Market Share by Type (2016-2021)

Figure 15. Semi-solid Dosage Consumed in Skin

Figure 16. Global Semi-solid Dosage Market: Skin (2016-2021) & (Dose)

Figure 17. Semi-solid Dosage Consumed in Nasal Cavity

Figure 18. Global Semi-solid Dosage Market: Nasal Cavity (2016-2021) & (Dose)

Figure 19. Semi-solid Dosage Consumed in Vaginal Cavity

Figure 20. Global Semi-solid Dosage Market: Vaginal Cavity (2016-2021) & (Dose)

Figure 21. Semi-solid Dosage Consumed in Rectal Cavity

Figure 22. Global Semi-solid Dosage Market: Rectal Cavity (2016-2021) & (Dose)

Figure 23. Semi-solid Dosage Consumed in Other

Figure 24. Global Semi-solid Dosage Market: Other (2016-2021) & (Dose)

Figure 25. Global Semi-solid Dosage Sales Market Share by Application (2016-2021)

Figure 26. Global Semi-solid Dosage Revenue Market Share by Application in 2020

Figure 27. Semi-solid Dosage Revenue Market by Company in 2020 ($ Million)

Figure 28. Global Semi-solid Dosage Revenue Market Share by Company in 2020

Figure 29. Global Semi-solid Dosage Sales Market Share by Regions (2016-2021)

Figure 30. Global Semi-solid Dosage Revenue Market Share by Region in 2020

Figure 31. Americas Semi-solid Dosage Sales 2016-2021 (Dose)

Figure 32. Americas Semi-solid Dosage Revenue 2016-2021 ($ Millions)

Figure 33. APAC Semi-solid Dosage Sales 2016-2021 (Dose)

Figure 34. APAC Semi-solid Dosage Revenue 2016-2021 ($ Millions)

Figure 35. Europe Semi-solid Dosage Sales 2016-2021 (Dose)

Figure 36. Europe Semi-solid Dosage Revenue 2016-2021 ($ Millions)

Figure 37. Middle East & Africa Semi-solid Dosage Sales 2016-2021 (Dose)

Figure 38. Middle East & Africa Semi-solid Dosage Revenue 2016-2021 ($ Millions)

Figure 39. Americas Semi-solid Dosage Sales Market Share by Country in 2020

Figure 40. Americas Semi-solid Dosage Revenue Market Share by Country in 2020

Figure 41. Americas Semi-solid Dosage Sales Market Share by Type in 2020

Figure 42. Americas Semi-solid Dosage Sales Market Share by Application in 2020

Figure 43. United States Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 44. Canada Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 45. Mexico Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 46. Brazil Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 47. APAC Semi-solid Dosage Sales Market Share by Region in 2020

Figure 48. APAC Semi-solid Dosage Revenue Market Share by Regions in 2020

Figure 49. APAC Semi-solid Dosage Sales Market Share by Type in 2020

Figure 50. APAC Semi-solid Dosage Sales Market Share by Application in 2020

Figure 51. China Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 52. Japan Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 53. Korea Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 54. Southeast Asia Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 55. India Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 56. Australia Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 57. Europe Semi-solid Dosage Sales Market Share by Country in 2020

Figure 58. Europe Semi-solid Dosage Revenue Market Share by Country in 2020

Figure 59. Europe Semi-solid Dosage Sales Market Share by Type in 2020

Figure 60. Europe Semi-solid Dosage Sales Market Share by Application in 2020

Figure 61. Germany Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 62. France Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 63. UK Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 64. Italy Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 65. Russia Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 66. Middle East & Africa Semi-solid Dosage Sales Market Share by Country in 2020

Figure 67. Middle East & Africa Semi-solid Dosage Revenue Market Share by Country in 2020

Figure 68. Middle East & Africa Semi-solid Dosage Sales Market Share by Type in 2020

Figure 69. Middle East & Africa Semi-solid Dosage Sales Market Share by Application in 2020

Figure 70. Egypt Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 71. South Africa Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 72. Israel Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 73. Turkey Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 74. GCC Country Semi-solid Dosage Revenue Growth 2016-2021 ($ Millions)

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles